MABXMISE
LIVE

Serial Number

79292460

Owner

PROMISE PROTEOMICS

Attorney

Rebeccah Gan

Filing Date

Jan 27, 2020

Add to watchlist:

No watchlists yet
View on USPTO

MABXMISE Trademark

Serial Number: 79292460 • Registration: 6297687

MABXMISE is a trademark filed by PROMISE PROTEOMICS on January 27, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

PROMISE PROTEOMICS (3 trademarks)

7 Parvis Louis Néel - Bht 52a -CS 20050
GRENOBLE CEDEX 9 F-38040 , FR

Entity Type: 34

Trademark Details

Filing Date

January 27, 2020

Registration Date

March 23, 2021

Published for Opposition

January 5, 2021

Goods & Services

Medical services; veterinary services; medical analysis services in relation to the treatment of individuals, namely, x-ray examinations for medical purposes, medical testing of blood, medical testing of urine, blood, hair follicles and breath, medical imaging services, medical testing for diagnostic or treatment purposes; DNA screening for medical purposes

Medicated skin care preparations; medicated skin care preparations for veterinary use; diagnostic preparations for veterinary purposes, chemical reagents for medical or veterinary purposes, proteins for medical or veterinary use, namely, protein arrays for medical diagnosis purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids

Chemicals for use in industry and science, biochemical catalysts, biochemical reagents used for non-medical purposes, biochemical preparations for scientific purposes, biological preparations for use in industry and science; proteins for industrial use, in raw materials form for scientific and medical research; diagnostic preparations used in science; diagnostic reagents and preparations, except for medical or veterinary use; immunohistochemistry detection kits consisting of mouse secondary reagents, DAB chromogens, DAB buffers, peroxidase blocking reagent, and hematoxylin, for anatomic pathology purposes in the medical diagnostics industry

Educational services, namely, providing tutorial sessions, panel discussions, non-downloadable webinars, seminars, and training in the fields of pharmaceuticals and biotechnology; publishing of books, manuals, magazines, and computer data intended for use on a computer or telephone network; electronic publishing services, namely, publication of text and graphic works of others on CD-ROMs in the fields of pharmaceuticals and biotechnology; organizing and conducting colloquiums, conferences and congresses in the fields of pharmaceuticals and biotechnology for educational purposes; organization of exhibitions for cultural or educational purposes; organization of events for cultural purposes; organizing events in the fields of pharmaceuticals and biotechnology for educational purposes

Scientific and industrial research in the fields of chemistry, biochemistry, biotechnology and biology; computer programming, and design, development, rental, updating and maintenance of software; engineering services in the nature of the provision of expert reports in the field of chemistry, biochemistry, biotechnologies and biology; technical advice, consultation and information all in the fields of biochemistry, biotechnologies and biology, namely, technical support and advice for drawing up, developing and implementing protein chemistry, protein biochemistry, biotechnologies and protein biology methods, protocols, and procedures; material testing, namely, testing of chemical, biochemical, biotechnology and biological materials and substances; research services in the chemical, biochemical, biotechnological and biological fields provided in laboratories; therapeutic strategies research and development services, namely, research and development in the pharmaceutical and biotechnology fields

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 23, 2026 REM3
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 27, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 27, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 27, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 27, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 27, 2021 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 16, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 16, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 16, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 16, 2021 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 24, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 2, 2021 FICS
FINAL DISPOSITION PROCESSED
Jul 2, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 23, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 23, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Jan 11, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 5, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jan 5, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 23, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 23, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 16, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 1, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 1, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 1, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 1, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 1, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 17, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 16, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 16, 2020 TROA
REFUSAL PROCESSED BY IB
Oct 19, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 29, 2020 RFCS
REFUSAL PROCESSED BY MPU
Sep 28, 2020 RFRR
APPLICATION FILING RECEIPT MAILED
Sep 1, 2020 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 30, 2020 RFCR
NON-FINAL ACTION WRITTEN
Aug 29, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 28, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 28, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 27, 2020 REPR